Navigation Links
Patheon to Showcase High Potency Capabilities at Upcoming Tradeshows
Date:4/12/2013

(PRWEB) April 12, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will showcase its high potency capabilities at the 2013 BIO International Convention in Chicago, Illinois on April 22 – 25, 2013, as well as at INTERPHEX 2013 in New York City on April 23 – 25, 2013.

High potent compounds are in the most stringently regulated categories in the industry, so strict adherence to the regulations and progressive modernization is required to manage the associated risks. Patheon has invested significant resources and maintains specialized teams to meet customer and regulatory standards, while maintaining a longstanding commitment to quality and safety. The company’s unique approach allows for high potent compounds to be taken quickly and cost-effectively from formulation to large-scale manufacturing with consistent, proven quality.

Patheon representatives will be available to discuss the company’s high potency capabilities, along with several other key service offerings, at the BIO International Convention (Booth #2370) and INTERPHEX (Booth #4123). More information is available at http://www.patheon.com/Knowledge-Library/Events.aspx.

To schedule a meeting in advance send an email to events(at)patheon(dot)com. All media inquiries or interview requests should be directed to media(at)patheon(dot)com.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10619358.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
2. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
3. Patheon to Present at Informex USA
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. Patheon to Present at 2013 DCAT Week
6. Patheon to Present New Updates in Drug Formulation and Bioavailability
7. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
8. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... and ANN ARBOR, Mich. , ... biopharmaceutical company developing breakthrough immune modulatory medicines, announced today ... the Company,s lead therapeutic candidate, LYC-30937- E nteric ... a debilitating skin disease that is estimated to affect ... United States , with approximately 1.5 - 3 ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... treatment and resource recovery solutions for industrial facilities, today announced that one of ... the first to use Cambrian’s novel water-energy purchase agreement (WEPA). Under the WEPA, ...
(Date:12/7/2016)... ... 2016 , ... JULABO USA is inviting visitors to explore ... has been designed to provide the best user-friendly experience coupled with intuitive navigation ... information, read educational industry content as well as share information across all major ...
(Date:12/7/2016)... ... 2016 , ... Kara Dwyer Dodge grew up hearing stories of the sea monster her father ... found a sea turtle entangled in the lines of one of his lobster pots. He ... because no one could remember ever seeing one so large so close to shore. After ...
Breaking Biology Technology:
(Date:11/21/2016)... Lithuania , Nov. 21, 2016   ... and object recognition technologies, today announced that the ... smart cards was submitted for the NIST ... successfully passed all the mandatory steps of the ... evaluation is a continuing test of fingerprint templates ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
Breaking Biology News(10 mins):